Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET [18F]-DOPA Ki

Parkinsonism and Related Disorders

Volumn 7, Issue 4, 2001, Pages 305-309

  Pal, P K ^a   Lee, C S ^a   Samii, A ^a   Schulzer, M ^a   Stoessl, A J ^a   Mak, E K ^a   Wudel, J ^a   Dobko, T ^a   Tsui, J K C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Finger tapping; Fluorodopa PET; Parkinson's disease; Rating scale

Indexed keywords

6 FLUORODOPA; ANTIPARKINSON AGENT; CARBIDOPA PLUS LEVODOPA;

ADULT; AGED; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; INDEX FINGER; MALE; METHODOLOGY; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; RIGIDITY;

EID: 0035050097     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(00)00048-1     Document Type: Article

References (13)

1. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
2. 18F]fluorodopa studies correlate with dopamine cell counts and levels
3. Core assessment program for intracerebral transplantation (CAPIT)
4. The pegboard as a measurement of parkinsonian deficit
5. Quantitative comparison of three- and two-dimensional PET with human brain studies
6. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects
7. 18F]fluorodopa positron emission tomographic studies
8. Clinical observations on the rate of progression of idiopathic parkinsonism
9. Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
10. Brain dopamine and the syndromes of Parkinson and Huntington
11. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
12. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease
13. A mathematical model of pathogenesis in idiopathic parkinsonism